• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)].

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2022 Nov 14;43(11):889-896. doi: 10.3760/cma.j.issn.0253-2727.2022.11.002.

DOI:10.3760/cma.j.issn.0253-2727.2022.11.002
PMID:36709178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9808868/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/d39e7176c666/cjh-43-11-889-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/fe11e0b04af1/cjh-43-11-889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/7219c9272c7d/cjh-43-11-889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/47553716c254/cjh-43-11-889-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/d39e7176c666/cjh-43-11-889-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/fe11e0b04af1/cjh-43-11-889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/7219c9272c7d/cjh-43-11-889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/47553716c254/cjh-43-11-889-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dba/9808868/d39e7176c666/cjh-43-11-889-g004.jpg

相似文献

1
[Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)].《输血依赖型β地中海贫血诊断与治疗中国指南（2022年版）》
Zhonghua Xue Ye Xue Za Zhi. 2022 Nov 14;43(11):889-896. doi: 10.3760/cma.j.issn.0253-2727.2022.11.002.
2
[Clinical practice guidelines for beta-thalassemia].[β地中海贫血临床实践指南]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):243-251. doi: 10.3760/cma.j.issn.1003-9406.2020.03.004.
3
Clinical Classification, Screening and Diagnosis for Thalassemia.地中海贫血的临床分类、筛查与诊断
Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006.
4
Treatment of beta-thalassemia.β地中海贫血的治疗
Curr Opin Hematol. 1997 Mar;4(2):79-87. doi: 10.1097/00062752-199704020-00002.
5
[Beta-thalassemia: clinical manifestations].[β地中海贫血：临床表现]
Bull Soc Pathol Exot. 2001 May;94(2):92-4.
6
Erythropoiesis is not equally suppressed in transfused males and females with β-thalassemia major: are there clinical implications?重度β地中海贫血输血男性和女性的红细胞生成抑制程度不同：这有临床意义吗？
Haematologica. 2015 Aug;100(8):e292-4. doi: 10.3324/haematol.2014.118216. Epub 2015 Apr 24.
7
Severe β-thalassemia intermedia in a compound heterozygous patient for the -30 (T>A) β(+)-thalassemia mutation and the δ(0)β(+)-Senegalese deletion.一名复合杂合子患者，携带 -30（T>A）β（+）-地中海贫血突变和δ（0）β（+）-塞内加尔缺失，患有重度中间型β-地中海贫血。
Hemoglobin. 2010;34(5):505-8. doi: 10.3109/03630269.2010.509230.
8
Beta-thalassemia.β地中海贫血
N Engl J Med. 2005 Sep 15;353(11):1135-46. doi: 10.1056/NEJMra050436.
9
Guidelines for diagnosis and management of Beta-thalassemia intermedia.中间型β地中海贫血的诊断与管理指南
Pediatr Hematol Oncol. 2014 Oct;31(7):583-96. doi: 10.3109/08880018.2014.937884.
10
Blood transfusion from a Hb E trait donor can affect β-thalassemia diagnosis.来自血红蛋白E性状供体的输血会影响β地中海贫血的诊断。
Hemoglobin. 2014;38(4):295-8. doi: 10.3109/03630269.2014.926913. Epub 2014 Jun 18.

引用本文的文献

1
Risk factors of low bone mass in young patients with transfusion-dependent beta-thalassemia.输血依赖型β地中海贫血年轻患者低骨量的危险因素
Front Endocrinol (Lausanne). 2025 Jul 2;16:1599437. doi: 10.3389/fendo.2025.1599437. eCollection 2025.
2
Preclinical efficacy and safety evaluation of BD211 autologous CD34 hematopoietic stem cell injection for transfusion-dependent β-thalassemia in NCG-X mice.BD211自体CD34造血干细胞注射液用于NCG-X小鼠输血依赖型β地中海贫血的临床前疗效和安全性评估
Front Cell Dev Biol. 2025 Jun 16;13:1607707. doi: 10.3389/fcell.2025.1607707. eCollection 2025.
3
[Guideline for transfusion management in Chinese children with transfusion-dependent thalassemia (2025)].

本文引用的文献

1
Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial.沙利度胺治疗输血依赖型β-地中海贫血患者的安全性和有效性：一项随机临床试验。
Signal Transduct Target Ther. 2021 Nov 18;6(1):405. doi: 10.1038/s41392-021-00811-0.
2
Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.肝静脉闭塞病/窦状隙阻塞综合征在重型地中海贫血患者造血干细胞移植后的发病情况、处理和结局。
Bone Marrow Transplant. 2021 Jul;56(7):1635-1641. doi: 10.1038/s41409-021-01233-w. Epub 2021 Feb 19.
3
[2025年中国儿童输血依赖型地中海贫血输血管理指南]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 May 15;27(5):505-514. doi: 10.7499/j.issn.1008-8830.2410119.
4
[Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia].[输血依赖型地中海贫血患儿的生长发育迟缓及相关因素]
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):328-335. doi: 10.3760/cma.j.cn121090-20240903-00333.
5
[Guidelines for iron chelation therapy in thalassemia in China (2025)].《中国地中海贫血铁螯合治疗指南（2025年版）》
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Apr 15;27(4):377-388. doi: 10.7499/j.issn.1008-8830.2411001.
6
Health-related quality of life and associated factors among children with Transfusion-dependent β-thalassaemia: a cross-sectional study in Guangxi Province.广西输血依赖型β-地中海贫血患儿的生活质量及相关因素的横断面研究
Health Qual Life Outcomes. 2024 Oct 29;22(1):93. doi: 10.1186/s12955-024-02307-1.
7
Post-transfusion severe headache in a patient with thalassemia with superficial siderosis of the central nervous system: a case report and literature review.输血后地中海贫血伴中枢神经系统表面铁沉积患者出现严重头痛：病例报告及文献复习。
BMC Neurol. 2024 Jan 6;24(1):21. doi: 10.1186/s12883-024-03526-1.
Co-Transplantation of Haploidentical Stem Cells and a Dose of Unrelated Cord Blood in Pediatric Patients with Thalassemia Major.
同种异体干细胞与无关脐带血共移植治疗重型地中海贫血患儿。
Cell Transplant. 2021 Jan-Dec;30:963689721994808. doi: 10.1177/0963689721994808.
4
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.CRISPR-Cas9 基因编辑治疗镰状细胞病和 β-地中海贫血。
N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5.
5
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.一项评估 luspatercept 治疗输血依赖型β地中海贫血患者的 3 期临床试验
N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182.
6
G-CSF-Mobilized Blood and Bone Marrow Grafts as the Source of Stem Cells for HLA-Identical Sibling Transplantation in Patients with Thalassemia Major.G-CSF 动员的血液和骨髓移植物作为重型地中海贫血患者 HLA 同胞移植干细胞的来源。
Biol Blood Marrow Transplant. 2019 Oct;25(10):2040-2044. doi: 10.1016/j.bbmt.2019.06.009. Epub 2019 Jun 15.
7
Deferiprone for the treatment of transfusional iron overload in thalassemia.去铁酮治疗地中海贫血输血所致铁过载
Expert Rev Hematol. 2017 Jun;10(6):493-503. doi: 10.1080/17474086.2017.1318052.
8
Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later.地中海贫血的移植：25年后重新审视佩萨罗风险因素
Am J Hematol. 2017 May;92(5):411-413. doi: 10.1002/ajh.24674. Epub 2017 Mar 22.
9
Transplantation for thalassemia major: alternative donors.重型地中海贫血的移植：替代供者
Curr Opin Hematol. 2016 Nov;23(6):515-523. doi: 10.1097/MOH.0000000000000280.
10
Matched sibling donor hematopoietic stem cell transplantation for thalassemia.地中海贫血的匹配同胞供者造血干细胞移植
Curr Opin Hematol. 2016 Nov;23(6):508-514. doi: 10.1097/MOH.0000000000000286.